Annual Working Capital
-$2.25 M
+$925.20 K+29.14%
December 1, 2023
Summary
- As of February 28, 2025, SKYE annual working capital is -$2.25 million, with the most recent change of +$925.20 thousand (+29.14%) on December 1, 2023.
- During the last 3 years, SKYE annual working capital has fallen by -$4.13 million (-219.87%).
- SKYE annual working capital is now -139.48% below its all-time high of $5.70 million, reached on December 1, 2021.
Performance
SKYE Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$74.18 M
+$1.50 M+2.07%
September 1, 2024
Summary
- As of February 28, 2025, SKYE quarterly working capital is $74.18 million, with the most recent change of +$1.50 million (+2.07%) on September 1, 2024.
- Over the past year, SKYE quarterly working capital has dropped by -$4.59 million (-5.82%).
- SKYE quarterly working capital is now -5.82% below its all-time high of $78.77 million, reached on March 1, 2024.
Performance
SKYE Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
SKYE Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +29.1% | -5.8% |
| 3 y3 years | -219.9% | +2242.6% |
| 5 y5 years | +83.9% | +2242.6% |
SKYE Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -139.5% | +29.1% | -5.8% | +1036.2% |
| 5 y | 5-year | -139.5% | +29.1% | -5.8% | +1036.2% |
| alltime | all time | -139.5% | +83.9% | -5.8% | +409.2% |
Skye Bioscience Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $74.18 M(+2.1%) |
| Jun 2024 | - | $72.68 M(-7.7%) |
| Mar 2024 | - | $78.77 M(-3600.5%) |
| Dec 2023 | -$2.25 M(-29.1%) | -$2.25 M(-243.5%) |
| Sep 2023 | - | $1.57 M(-119.8%) |
| Jun 2023 | - | -$7.92 M(+61.2%) |
| Mar 2023 | - | -$4.92 M(+54.8%) |
| Dec 2022 | -$3.18 M(-155.7%) | -$3.18 M(-8.3%) |
| Sep 2022 | - | -$3.46 M(+647.8%) |
| Jun 2022 | - | -$463.00 K(-116.5%) |
| Mar 2022 | - | $2.81 M(-50.7%) |
| Dec 2021 | $5.70 M(+203.6%) | $5.70 M(-42.6%) |
| Sep 2021 | - | $9.93 M(+153.3%) |
| Jun 2021 | - | $3.92 M(-1.9%) |
| Mar 2021 | - | $4.00 M(+112.9%) |
| Dec 2020 | $1.88 M(+83.3%) | $1.88 M(-40.2%) |
| Sep 2020 | - | $3.14 M(-262.7%) |
| Jun 2020 | - | -$1.93 M(+93.7%) |
| Mar 2020 | - | -$995.80 K(-197.2%) |
| Dec 2019 | $1.02 M(-107.3%) | $1.02 M(-108.2%) |
| Sep 2019 | - | -$12.54 M(+56.3%) |
| Jun 2019 | - | -$8.03 M(-66.5%) |
| Mar 2019 | - | -$23.99 M(+71.5%) |
| Dec 2018 | -$13.99 M | -$13.99 M(+37.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | -$10.16 M(+23.1%) |
| Jun 2018 | - | -$8.25 M(-391.2%) |
| Mar 2018 | - | $2.83 M(-1232.5%) |
| Dec 2017 | -$250.20 K(-34.6%) | -$250.20 K(-81.5%) |
| Sep 2017 | - | -$1.35 M(+81.6%) |
| Jun 2017 | - | -$743.60 K(+335.1%) |
| Mar 2017 | - | -$170.90 K(-55.3%) |
| Dec 2016 | -$382.50 K(-113.3%) | -$382.50 K(+85.6%) |
| Sep 2016 | - | -$206.10 K(-138.9%) |
| Jun 2016 | - | $529.30 K(-70.5%) |
| Mar 2016 | - | $1.79 M(-37.5%) |
| Dec 2015 | $2.87 M(-682.9%) | $2.87 M(-26.1%) |
| Sep 2015 | - | $3.89 M(-534.9%) |
| Jun 2015 | - | -$893.90 K(+138.8%) |
| Mar 2015 | - | -$374.40 K(-24.0%) |
| Dec 2014 | -$492.70 K(-1224.9%) | -$492.70 K(-165.2%) |
| Sep 2014 | - | $755.30 K(+2051.9%) |
| Jul 2014 | - | $35.10 K(-9.1%) |
| Apr 2014 | - | $38.60 K(-22.5%) |
| Jan 2014 | - | $49.80 K(+13.7%) |
| Oct 2013 | $43.80 K(+28.8%) | $43.80 K(+92.1%) |
| Jul 2013 | - | $22.80 K(+90.0%) |
| Apr 2013 | - | $12.00 K(-64.7%) |
| Oct 2012 | $34.00 K | $34.00 K |
FAQ
- What is Skye Bioscience annual working capital?
- What is the all time high annual working capital for Skye Bioscience?
- What is Skye Bioscience annual working capital year-on-year change?
- What is Skye Bioscience quarterly working capital?
- What is the all time high quarterly working capital for Skye Bioscience?
- What is Skye Bioscience quarterly working capital year-on-year change?
What is Skye Bioscience annual working capital?
The current annual working capital of SKYE is -$2.25 M
What is the all time high annual working capital for Skye Bioscience?
Skye Bioscience all-time high annual working capital is $5.70 M
What is Skye Bioscience annual working capital year-on-year change?
Over the past year, SKYE annual working capital has changed by +$925.20 K (+29.14%)
What is Skye Bioscience quarterly working capital?
The current quarterly working capital of SKYE is $74.18 M
What is the all time high quarterly working capital for Skye Bioscience?
Skye Bioscience all-time high quarterly working capital is $78.77 M
What is Skye Bioscience quarterly working capital year-on-year change?
Over the past year, SKYE quarterly working capital has changed by -$4.59 M (-5.82%)